ClinicalTrialsFinder

HER2-low Expressing Breast Cancer Clinical Trials in Alcabideche, Lisboa

1 recruitingAlcabideche, Lisboa, Portugal

Showing 1–1 of 1 trials

Recruiting

DESTINY Breast Respond HER2-low Europe

Metastatic Breast CancerUnresectable Breast CancerHER2-low Expressing Breast Cancer
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1,155 enrolled211 locationsNCT05945732